Back
Relmada Therapeutics Vs. Corvus Pharmaceuticals Industry Stock Comparison
Sell
25
RLMD
Relmada Therapeutics
Last Price:
3.35
Seasonality Move:
-10.66%
Buy
84
CRVS
Corvus Pharmaceuticals
Last Price:
2.29
Seasonality Move:
3.43%
Sell
25
Relmada Therapeutics (RLMD)
is a Sell
Is Relmada Therapeutics a Buy, Sell or Hold?
- The current Relmada Therapeutics [RLMD] share price is $3.34. The Score for RLMD is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- RLMD is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
84
Corvus Pharmaceuticals (CRVS)
is a Buy
Is Corvus Pharmaceuticals a Buy, Sell or Hold?
- The current Corvus Pharmaceuticals [CRVS] share price is $2.29. The Score for CRVS is 84, which is 68% above its historic median score of 50, and infers lower risk than normal.
- CRVS is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
RLMD Stock Price Chart
What is Relmada Therapeutics's stock price today?
-
The Relmada Therapeutics share price today is $3.34
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RLMD is experiencing selling pressure, which indicates risk of future bearish movement.
CRVS Stock Price Chart
What is Corvus Pharmaceuticals's stock price today?
-
The Corvus Pharmaceuticals share price today is $2.29
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRVS is experiencing buying pressure, which is a positive indicator for future bullish movement.
RLMD Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.26 | Sell |
Relative Strength Index (14 RSI): | 32.15 | Sell |
Chaikin Money Flow: | -36523 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.5 - 4.16) | Sell |
Bollinger Bands (100): | (3.57 - 5.47) | Sell |
CRVS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.15 | Buy |
Relative Strength Index (14 RSI): | 69.2 | Buy |
Chaikin Money Flow: | 139526 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.44 - 2.06) | Buy |
Bollinger Bands (100): | (1.68 - 2.22) | Buy |
RLMD Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.58 | Sell |
20-day SMA: | 3.69 | Sell |
50-day SMA: | 4.41 | Sell |
200-day SMA: | 3.76 | Sell |
8-day EMA: | 3.55 | Sell |
20-day EMA: | 3.77 | Sell |
50-day EMA: | 4.17 | Sell |
200-day EMA: | 4.36 | Sell |
CRVS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.14 | Buy |
20-day SMA: | 1.83 | Buy |
50-day SMA: | 1.78 | Buy |
200-day SMA: | 1.79 | Buy |
8-day EMA: | 2.13 | Buy |
20-day EMA: | 1.94 | Buy |
50-day EMA: | 1.85 | Buy |
200-day EMA: | 1.81 | Buy |
Relmada Therapeutics Earnings Growth & RLMD Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.22 per share, and an increase next year of $0.26 per share.
Corvus Pharmaceuticals Earnings Growth & CRVS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.03 per share, an increase this year of $0.07 per share, and a decrease next year of $0.07 per share.
Relmada Therapeutics Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Corvus Pharmaceuticals Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |